Previous Article | Next Article ![]()
J. Virol., 02 1996, 801-808, Vol 70, No. 2
B Garcia-Barreno, T Delgado and JA Melero
We have reported previously that the nucleoprotein (N), the phosphoprotein
(P), and the 22-kDa protein of human respiratory syncytial virus (HRSV) are
components of the cytoplasmic inclusion bodies observed in HEp-2-infected
cells. In addition, coexpression of N and P was sufficient to induce the
formation of N-P complexes detectable by either coimmunoprecipitation with
anti-P antibodies or generation of cytoplasmic inclusions. We now report
the identification of protein regions required for these interactions.
Deletion mutant analysis of the P protein gene indicated that its
C-terminal end was essential for interacting with N. This conclusion was
strengthened by the finding that an anti-P monoclonal antibody (021/12P),
reacting with a 21-residue P protein C-terminal peptide, apparently
displaced N from N-P complexes. The same effect was observed with high
concentrations of the C-terminal peptide. However, sequence requirements
for the P protein C-terminal end were not absolute, and mutants with the
substitution Ser-237-->Ala or Ser-237-->Thr were as efficient as the
wild type in interacting with N. In addition, P and N proteins from strains
of different HRSV antigenic groups, with sequence differences in the P
protein C-terminal end, were able to coimmunoprecipitate and formed
cytoplasmic inclusions. Deletion mutant analysis of the N gene indicated
that large segments of this polypeptide were required for interacting with
P. The relevance of these interactions for HRSV is discussed in comparison
with those of analogous proteins from related viruses.
Copyright © 1996, American Society for Microbiology
Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions
Instituto de Salud Carlos III, Centro Nacional de Biologia Celular y Retrovirus, Madrid, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|